Degenerative disease describes a class of conditions in which cells, tissues or organs undergo gradual structural and functional decline over time. The term applies across body systems — from cartilage and intervertebral discs to neurons and heart muscle — and emphasizes progressive loss rather than an acute or infectious process. For a concise definition that focuses on affected anatomy see affected tissues or organs.

Pathophysiology and key characteristics

Although mechanisms vary by disease, degenerative conditions share common features: ongoing cell damage, loss of normal tissue architecture, and cumulative impairment of organ function. Typical pathological processes include:

  • Protein misfolding and aggregation — seen in many neurodegenerative disorders.
  • Programmed cell death (apoptosis) and other forms of cell loss.
  • Chronic inflammation that sustains tissue injury.
  • Mechanical wear or structural breakdown in musculoskeletal disease.
  • Ischemia and metabolic stress contributing to progressive dysfunction.

Types and representative examples

Degenerative diseases occur in multiple organ systems. In the nervous system, neurodegeneration refers to progressive loss of neurons and their connections; this process underlies conditions commonly classified as neurodegenerative disorders (neurodegeneration overview). Examples include Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and Huntington's disease. Outside the nervous system, degenerative conditions include osteoarthritis, degenerative disc disease, and some forms of cardiomyopathy.

Causes and risk factors

Multiple influences can initiate or accelerate degeneration. Major contributors are:

  • Aging — the single strongest risk factor for many degenerative disorders.
  • Genetic predisposition — inherited mutations can increase vulnerability.
  • Environmental exposures — toxins, repeated trauma, or lifestyle factors.
  • Metabolic and vascular disease — diabetes, poor circulation, and related conditions.
  • Immune-mediated processes that chronically damage tissue.

Diagnosis, progression and management

Diagnosis typically combines clinical assessment with imaging, laboratory tests and, increasingly, molecular biomarkers. Many degenerative diseases are progressive and currently incurable; care therefore focuses on slowing progression, managing symptoms and maintaining quality of life. Approaches include pharmacologic treatments that target specific pathways, rehabilitation (physical and occupational therapy), surgical interventions when structural damage is pronounced, and multidisciplinary support for cognitive or functional decline. Research into disease-modifying therapies and early detection is an active and evolving field.

Understanding degenerative disease requires distinguishing it from reversible, infectious, or congenital disorders. Its rising clinical and social importance reflects aging populations worldwide and the long-term burden these conditions place on patients, families and health systems. For further reading and summaries of specific conditions, consult specialty resources and reviews (overview resources, neurodegenerative resources, Alzheimer's information).